Using Cognizant’s top-tier controlled services and products frameworks and gear, the partnership targets to toughen Alnylam’s automation and let fall operational efforts
TEANECK, N.J., Oct. 29, 2024 /PRNewswire/ — Cognizant (Nasdaq: CTSH) introduced as of late a untouched commitment with Alnylam Pharmaceuticals, Inc., a chief biopharmaceutical corporate and the pioneer in RNA interference (RNAi) therapeutics. Cognizant will provide as an integral IT Controlled Services and products supplier for Alnylam. This collaboration targets to scale Alnylam’s IT operations and boost up its functions in turning in transformative medications.
Cognizant has been decided on because the era spouse answerable for managing Alnylam’s world infrastructure and operations, cloud, safety, platforms, packages, and complex knowledge analytics. Leveraging Cognizant’s controlled services and products frameworks and gear, the collaboration targets to strengthen automation, let fall operational efforts, and assure transparency in industry choices and unified efficiency responsibility.
“By leveraging Cognizant’s expertise in the life sciences sector and innovative managed services frameworks, we will aim to accelerate our business outcomes and ultimately improve customer experiences,” mentioned Larry Egan, Vice President of Strategic Applied sciences at Alnylam.
Thirty of the peak world pharmaceutical firms paintings with Cognizant to enforce and lead complex era answers, enabling them in order their leading edge medication to marketplace, run world provide chains and production programs, and agree to advanced laws.
“We are thrilled to partner with Alnylam on its IT transformation journey,” mentioned Cognizant’s Mohammad Haque, SVP, International Massive Offer Top and BU Head, Generation Sciences. “We will bring our extensive experience with large pharmaceutical companies, along with investments in AI, to accelerate Alnylam’s business goals. As a strategic partner, we look forward to helping Alnylam grow its business and continue delivering transformative medicines to treat both rare and prevalent diseases.”
About Cognizant
Cognizant (Nasdaq: CTSH) engineers trendy companies. We backup our shoppers modernize era, reimagine processes and develop into reports so they may be able to keep forward in our fast-changing international. In combination, we’re making improvements to on a regular basis year. See how at www.cognizant.com or @cognizant.
Touch:
Natalie Steffen
[email protected]
SOURCE Cognizant Generation Answers
WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Virtual Media
Shops
270k+
Reporters
Opted In
